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PMRC Research Centre, Jinnah Postgraduate Medical Centre and Department of Biochemistry, The Aga Khan University Hospital*, Karachi. 
Introduction 
Alpha 1 antitrypsin (a 1 Al) deficiency and its 
association with the pathogenesis of liver disease con-
tinues to be controversial. Recent biochemical charac-
terization also indicates that its involvement in liver 
disease is obscurer. The deficiency itself may not be a 
cause of liver disease as it occurs with almost the same 
frequency in patients with and without liver disease2'3. 
The present study was conducted to determine the 
association of serum alpha 1 antitrypsin with various 
types of acute and chronic liver diseases. 
Patients, Methods and Results 
Fifty patients suffering from acute viral hepatitis 
(AVH), 50 biopsy proven cirrhotics and 100 healthy 
adults were selected. Controls were included on the 
basis of normal liver function tests whereas liver diseases 
were classified on clinical examination, biochemical 
investigations, i.e., liver function tests and liver biopsy. 
Raised aspartate and alanine transaminase (three times 
the normal) was the criteria for selecting patients with 
AVH while all cirrhotics were biopsy proven. Age and sex 
distribution in controls and patients with liver disease is 
Table. Age and sex distribution in controls and patients with AYH 
and cirrhosis. 
Groups 
M 
Sex 
F 
Age (years) 
Mean (range) 
Controls 52 48 33 
(100) (18-82) 
Acute viral 
hepatitis 
37 13 32 
(50) (18-60) 
Cirrhosis 26 24 42 
(50) (18-75) 
presented in the accompanying table. 
Quantitative measurement of serum alpha 1 an-
titrypsin was carried out by single radial immunodif-
fusion (RID) technique using M. Partigen immunodif-
fusion plates4 (Behring Diagnostic) while phenotyping 
was done by ultra thin layer polyacrylamide gel 
isoelectric focussing (IEF) and for further confirmation 
of alpha 1 antitrypsin bands we used immunofixation 
techniques. 
Mean serum alpha 1 antitrypsin concentration by 
RID in healthy controls was 2.47-1.-0.08 g/1 (range 
0.52-5.0 g/1). Any value less than 2.0 g/1 was considered 
lower than normal. In patients with AVH the concentra-
tion varied from 0.52-4.7 g/I (mean 3.2 ± 0.11 g/1). With 
the exception of one patient, all others had values within 
the normal expected range, while 12% cirrhotics had low 
concentrations, mean being 2.71 ±0.11 g/l. IEF profile in 
controls showed that phenotype MM predominates 
(70%) followed by M1 M2 (28%) and FM3 (2%). MM is 
also the most common phenotype in patients with AVH 
(72%) and cirrhosis (52%) while M1 M2 was found in 28% 
and 48% of the patients respectively. 
Comments 
The present findings indicate that almost 98% of the 
patients with acute viral hepatitis had values within the 
normal expected range while 12% cirrhotics manifested 
low levels. These low levels, however, appear to be of no 
diagnostic significance as not a single sera exhibited total 
or intermediate deficiency phenotype when subjected to 
isoelectric focussing. The study therefore supports the 
notion that phenotypes associated with both total or 
intermediate deficiencies are less in our local population 
than in Europeans6'7 and American caucasians8. 
Phenotype MM overwhelmingly dominates all 
other types and thus can be regarded as the normal type 
for our population. 
References 
1. Propst, T., Propst, A., Dietz, 0. et al. High prevalence of viral infection in adults with 
homozygous and heterozygous alpha 1 antitrypsin deficiency and chronic liver disease. 
Ann. Intern.Med., 1992;117:641-45. 
2. Hodges, J.R., Millward-Sadler, G.H., Barbatis, C. et al. Heterozygous MZ alpha 1 
antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. 
N.EnglaMed., 1981;304:557-60. 
3. Fisher, R.L., Taylor, L and Sherlock, S. Alpha 1 antitrypsin deficiency, the extent of the 
problem. Gastroent., 1976;71:346- 51. 
4. Mancini, G., Carbonarer, A.O. and Hereman, SJ.F. Immunochemical quantitation of 
antigens by single radial immunodiffusion. lmmunochem., 1965;2:235-54. 
5. Jeppsson,.1.0. and Franzen, B. Typingof geneticvariants of alpha 1 antitrypsin byelectro 
focusing. Clin.Chem., 1982;28:219- 25. 
6. Carrell, R.W. and Owen, M.C. Alpha 1 antitrypsin, structure, variation and disease. 
Essays. Med. Biochem., 1979;4:83-119. 
7. Sveger, T. Liver disease in alpha 1- an titrypsin deficiency detected by screening of 200,000 
infants. N.Engi.J.Med., 1976;294:1316-21. 
8. Perlmutter, D.H. and Pierce, J.A. The alpha 1 antitrypsin gene and emphysema. 
AmeraPhysiol., 1989;1,147-62. 
72 	 Vol. 44, No.3, March, 1994 
